BioMarin Pharmaceuticals
BMRN
BMRN
313 hedge funds and large institutions have $10.4B invested in BioMarin Pharmaceuticals in 2014 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 119 increasing their positions, 109 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
5% more capital invested
Capital invested by funds: $9.95B → $10.4B (+$450M)
10% less call options, than puts
Call options by funds: $116M | Put options by funds: $128M
Holders
313
Holding in Top 10
8
Calls
$116M
Puts
$128M
Top Buyers
| 1 | +$329M | |
| 2 | +$301M | |
| 3 | +$106M | |
| 4 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$61.8M |
| 5 |
State Street
Boston,
Massachusetts
|
+$48.2M |
Top Sellers
| 1 | -$93.9M | |
| 2 | -$62.5M | |
| 3 | -$44.7M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$43.6M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$39.6M |